Download PDF

1. Company Snapshot

1.a. Company Description

DocGo, Inc.provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom.The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.


It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts.DocGo, Inc.was incorporated in 2015 and is headquartered in New York, New York.

Show Full description

1.b. Last Insights on DCGO

DocGo Inc.'s recent performance was driven by several factors. The company's Q2 2025 earnings call revealed a quarterly loss of $0.11 per share, beating revenue estimates. A new contract with a major New York health system to provide digital transportation management and dedicated ambulance services also contributed positively. Additionally, the launch of a mobile health vaccination program for the County of San Diego and a $3.4 million contract to provide medical transportation services to the Albany Stratton VA Medical Center expanded the company's services. However, investigations into alleged false statements about the former CEO's educational background and business development efforts may impact investor confidence.

1.c. Company Highlights

2. DocGo's Q3 Earnings: A Mixed Bag

DocGo reported total revenue of $70.8 million for 2025, down from $138.7 million in 2024, with adjusted EBITDA loss of $7.1 million compared to a profit of $17.9 million in 2024. The adjusted gross margin was 33% in 2025, down from 36% in 2024. The company's EPS came in at -$0.11, missing estimates of -$0.09. Excluding revenue from migrant-related programs, revenue increased by 8% to $62.4 million in 2025 from $58 million in 2024, driven by growth in medical transportation services and non-migrant mobile health revenues.

Publication Date: Nov -20

📋 Highlights
  • Record Base Business Growth: Achieved 8% revenue increase in non-migrant services to $62.4M in 2025, driven by 20% YoY growth in care gap closures, RPM, and mobile phlebotomy.
  • 2026 Revenue Guidance: Targeting $280–$300M revenue (12–20% YoY base growth), with transport expected to contribute ~$200M in 2025 and scale further in 2026.
  • SteadyMD Acquisition Impact: Acquired virtual care provider to scale 50-state clinician network, enabling efficient care delivery and potentially boosting 2026 top-line revenue by millions.
  • Payer & Provider Vertical Growth: Revenue to rise from $50M in 2025 to $85M in 2026, fueled by telehealth, RPM, and care gap closure services.
  • Improved Cash Position: Cash balance expected to reach $95M by year-end 2025, with $65M+ projected by 2026 post-SteadyMD, and 96% of migrant receivables collected to date.

Revenue Growth Drivers

The transportation business achieved record volumes in Q3, driven by long-term contracts, and is expected to generate over $200 million of revenue in 2026. The payer and provider vertical is expected to grow to $85 million in 2026, driven by services such as care gap closure, primary and preventative care, telehealth, and remote patient monitoring. The remote patient monitoring business is focused on cardiology and has signed 13 new contracts this year, with eight more proposals in the pipeline.

Acquisition and Integration

The acquisition of SteadyMD is expected to enable DocGo to achieve more efficient delivery of patient care by pairing its mobile health clinicians with SteadyMD's virtual clinician workforce. The deal is expected to bring significant value to shareholders, with the potential to drive growth and improve margins. As Norman Rosenberg noted, "We believe we got a very attractive deal for our shareholders with the way we structured this transaction and the value it brings."

Valuation and Outlook

With a P/S Ratio of 0.21 and EV/EBITDA of -3.56, the market appears to be pricing in significant growth potential for DocGo. However, the company's guidance for 2026 revenue of $280 million to $300 million represents a decline of 12% to 20% from 2025 levels, excluding migrant-related revenues. The expected improvement in gross margins and reduction in operating expenses should help drive EBITDA performance in 2026.

Margins and Expenses

The company's adjusted gross margin is expected to improve over the next few quarters, driven by the expansion of its field labor team and the integration of SteadyMD. Operating expenses are expected to be reduced through cost-saving measures, which should help drive EBITDA performance in 2026. The EBITDA loss is expected to be skewed towards the first half of 2026, with a smaller loss in the third quarter and potentially a positive number in the fourth quarter.

3. NewsRoom

Card image cap

DocGo Inc. (DCGO) Q3 2025 Earnings Call Transcript

Nov -11

Card image cap

DocGo Inc. (DCGO) Reports Q3 Loss, Beats Revenue Estimates

Nov -11

Card image cap

DocGo Announces Upcoming Launch of Longitudinal Care Services for Major California Health Plan

Nov -04

Card image cap

Halper Sadeh LLC Encourages DocGo Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct -23

Card image cap

DocGo Inc. (DCGO) M&A Call Transcript

Oct -21

Card image cap

DocGo Acquires Virtual Care Platform SteadyMD, Expands Telehealth Services Across All 50 States

Oct -20

Card image cap

DocGo Signs Deal to Launch Care Gap Closure Program in New Mexico With National Insurance Provider

Oct -16

Card image cap

DRIVEN BRANDS INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Driven Brands Holdings Inc. - DRVN

Sep -18

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (10.12%)

6. Segments

Mobile Health

Expected Growth: 10.78%

DocGo's Mobile Health segment growth of 10.78% is driven by increasing demand for convenient, on-demand healthcare services, expansion into new markets, and strategic partnerships. Additionally, the company's focus on technology integration, such as telemedicine and AI-powered platforms, enhances patient experience and improves operational efficiency, contributing to the segment's rapid growth.

Transportation

Expected Growth: 8.5%

DocGo Inc.'s 8.5% growth in Transportation is driven by increasing demand for non-emergency medical transportation, expansion into new markets, and strategic partnerships with healthcare providers. Additionally, investments in technology and operational efficiency have improved customer experience, leading to higher retention rates and revenue growth.

7. Detailed Products

Ambulance Services

DocGo provides ambulance services to transport patients to medical facilities, including emergency and non-emergency transportation.

Mobile Health Services

DocGo offers mobile health services, including on-site medical care and telemedicine services, to provide patients with convenient and accessible healthcare.

Medical Transportation Services

DocGo provides medical transportation services, including wheelchair and stretcher transportation, to patients who require non-emergency medical transportation.

Telemedicine Services

DocGo offers telemedicine services, allowing patients to remotely consult with healthcare professionals through video conferencing.

Mobile Diagnostics Services

DocGo provides mobile diagnostics services, including on-site laboratory testing and imaging services, to patients in their homes or offices.

8. DocGo Inc.'s Porter Forces

Forces Ranking

Threat Of Substitutes

DocGo Inc. faces moderate threat from substitutes as patients have limited alternatives for non-emergency medical transportation services.

Bargaining Power Of Customers

DocGo Inc. has a diversified customer base, which reduces the bargaining power of individual customers.

Bargaining Power Of Suppliers

DocGo Inc. relies on a network of healthcare providers and transportation partners, which gives them moderate bargaining power.

Threat Of New Entrants

The non-emergency medical transportation industry has low barriers to entry, making it easier for new entrants to disrupt the market.

Intensity Of Rivalry

The non-emergency medical transportation industry is highly competitive, with multiple players competing for market share.

9. SWOT Analysis

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 13.39%
Debt Cost 8.75%
Equity Weight 86.61%
Equity Cost 8.75%
WACC 8.75%
Leverage 15.46%

11. Quality Control: DocGo Inc. passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
The Oncology Institute

A-Score: 4.6/10

Value: 9.4

Growth: 3.2

Quality: 4.4

Yield: 0.0

Momentum: 10.0

Volatility: 0.7

1-Year Total Return ->

Stock-Card
DocGo

A-Score: 4.1/10

Value: 9.8

Growth: 8.3

Quality: 4.4

Yield: 0.0

Momentum: 0.0

Volatility: 2.0

1-Year Total Return ->

Stock-Card
Brookdale Senior Living

A-Score: 3.9/10

Value: 5.1

Growth: 3.1

Quality: 2.1

Yield: 0.0

Momentum: 9.0

Volatility: 4.3

1-Year Total Return ->

Stock-Card
Sonida Senior Living

A-Score: 3.9/10

Value: 5.8

Growth: 2.7

Quality: 2.1

Yield: 0.0

Momentum: 7.5

Volatility: 5.3

1-Year Total Return ->

Stock-Card
AirSculpt Technologies

A-Score: 3.7/10

Value: 4.6

Growth: 4.8

Quality: 2.5

Yield: 1.0

Momentum: 8.0

Volatility: 1.3

1-Year Total Return ->

Stock-Card
The Joint

A-Score: 3.2/10

Value: 3.3

Growth: 3.3

Quality: 4.9

Yield: 0.0

Momentum: 3.5

Volatility: 4.0

1-Year Total Return ->

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

1.05$

Current Price

1.05$

Potential

-0.00%

Expected Cash-Flows